FSMEX vs. VGHCX
Compare and contrast key facts about Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Vanguard Health Care Fund Investor Shares (VGHCX).
FSMEX is managed by Fidelity. It was launched on Apr 28, 1998. VGHCX is managed by Vanguard. It was launched on May 23, 1984.
Performance
FSMEX vs. VGHCX - Performance Comparison
Loading graphics...
FSMEX vs. VGHCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FSMEX Fidelity Select Medical Technology and Devices Portfolio | -17.58% | 8.13% | 18.37% | 0.62% | -24.84% | 24.56% | 30.18% | 29.58% | 15.98% | 26.66% |
VGHCX Vanguard Health Care Fund Investor Shares | -5.90% | 19.63% | 8.99% | 5.46% | -1.05% | 14.36% | 12.57% | 22.93% | 1.03% | 19.59% |
Returns By Period
In the year-to-date period, FSMEX achieves a -17.58% return, which is significantly lower than VGHCX's -5.90% return. Over the past 10 years, FSMEX has outperformed VGHCX with an annualized return of 10.46%, while VGHCX has yielded a comparatively lower 9.25% annualized return.
FSMEX
- 1D
- -0.58%
- 1M
- -11.19%
- YTD
- -17.58%
- 6M
- -11.01%
- 1Y
- -8.83%
- 3Y*
- 0.36%
- 5Y*
- -0.71%
- 10Y*
- 10.46%
VGHCX
- 1D
- 0.43%
- 1M
- -8.80%
- YTD
- -5.90%
- 6M
- 7.14%
- 1Y
- 9.73%
- 3Y*
- 9.19%
- 5Y*
- 7.98%
- 10Y*
- 9.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FSMEX vs. VGHCX - Expense Ratio Comparison
FSMEX has a 0.68% expense ratio, which is higher than VGHCX's 0.30% expense ratio.
Return for Risk
FSMEX vs. VGHCX — Risk / Return Rank
FSMEX
VGHCX
FSMEX vs. VGHCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Vanguard Health Care Fund Investor Shares (VGHCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FSMEX | VGHCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.41 | 0.53 | -0.93 |
Sortino ratioReturn per unit of downside risk | -0.46 | 0.83 | -1.29 |
Omega ratioGain probability vs. loss probability | 0.94 | 1.10 | -0.16 |
Calmar ratioReturn relative to maximum drawdown | -0.48 | 1.14 | -1.62 |
Martin ratioReturn relative to average drawdown | -1.55 | 2.80 | -4.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FSMEX | VGHCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.41 | 0.53 | -0.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | 0.44 | -0.48 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | 0.53 | -0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.65 | 0.93 | -0.28 |
Correlation
The correlation between FSMEX and VGHCX is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FSMEX vs. VGHCX - Dividend Comparison
FSMEX's dividend yield for the trailing twelve months is around 12.78%, more than VGHCX's 7.02% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 12.78% | 10.53% | 17.04% | 0.00% | 1.80% | 8.12% | 6.65% | 1.77% | 7.47% | 6.26% | 5.84% | 16.35% |
VGHCX Vanguard Health Care Fund Investor Shares | 7.02% | 6.00% | 22.72% | 7.17% | 5.44% | 8.31% | 7.96% | 11.82% | 9.10% | 7.30% | 8.54% | 8.16% |
Drawdowns
FSMEX vs. VGHCX - Drawdown Comparison
The maximum FSMEX drawdown since its inception was -40.34%, which is greater than VGHCX's maximum drawdown of -36.93%. Use the drawdown chart below to compare losses from any high point for FSMEX and VGHCX.
Loading graphics...
Drawdown Indicators
| FSMEX | VGHCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.34% | -36.93% | -3.41% |
Max Drawdown (1Y)Largest decline over 1 year | -21.04% | -9.20% | -11.84% |
Max Drawdown (5Y)Largest decline over 5 years | -40.34% | -16.95% | -23.39% |
Max Drawdown (10Y)Largest decline over 10 years | -40.34% | -27.18% | -13.16% |
Current DrawdownCurrent decline from peak | -22.82% | -8.80% | -14.02% |
Average DrawdownAverage peak-to-trough decline | -7.66% | -5.25% | -2.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.50% | 3.91% | +2.59% |
Volatility
FSMEX vs. VGHCX - Volatility Comparison
Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a higher volatility of 5.85% compared to Vanguard Health Care Fund Investor Shares (VGHCX) at 4.82%. This indicates that FSMEX's price experiences larger fluctuations and is considered to be riskier than VGHCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FSMEX | VGHCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.85% | 4.82% | +1.03% |
Volatility (6M)Calculated over the trailing 6-month period | 12.32% | 10.26% | +2.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.03% | 17.43% | +3.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.75% | 18.05% | +2.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.59% | 17.62% | +2.97% |